1. HBW Insight
  2. >>Health
  3. >>Policy & Regulation
  4. >>Regulation

Label Warnings Against Driving Start Arriving For OTC Sleep Ingredients In US

 
• By Malcolm Spicer

Unisom Sleeptab with 25 mg doxylamine is first OTC sleep remedy adding warning not to drive a vehicle or operate machinery and five others FDA requested in “changes being effected” letter. Agency’s ongoing review found “labeling deficiencies” with doxylamine and diphenhydramine.

• Source: Shutterstock

The US Food and Drug Administration didn’t sleep on changes needed in labeling for Unisom Sleeptab and coming for other OTCs formulated with doxylamine or diphenhydramine, including analgesics also containing either of the sleep ingredients.

The FDA Center for Drug Evaluation and Research contacted Sanofi’s US business marketing the Unisom brand, Chattem Inc., a...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation

FDA Takes World Tour In Recent OTC Warnings

 
• By Malcolm Spicer

FDA Center for Drug Evaluation and Research Office of Manufacturing Quality, Office of Compliance and Office of Unapproved Drugs & Labeling Compliance recently advise Indian, Canadian and US firms about GMP problems.

German Associations Call For EU Green Claims Directive Trilogue Suspension

 
• By David Ridley

Pharma Deutschland is one of 21 German associations calling for trilogue negotiations in relation to the EU Green Claims Directive to be suspended while a “comprehensive and independent written impact assessment” is undertaken.

Over The Counter: EU Omnibus And ESG, What You Need To Know, With CEN Group’s Jasper Crone

 
• By David Ridley

HBW Insight catches up with sustainability expert Jasper Crone to find out what consumer health companies need to know about the European Commission's Omnibus simplification package.